Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Dementia

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

Alzheimer Disease ll: Pathophysiology

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management of Charles Bonnet syndrome in routine eye care services.

Eye (London, England)·2026

Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Same author

Cohort Profile: Our Future Health.

International journal of epidemiology·2025

Same author

Aprosopsia: a novel metamorphopsia variant occurring in Parkinson's disease psychosis.

Journal of neurology·2025

Same author

Visual cortical activity in Charles Bonnet syndrome: testing the deafferentation hypothesis.

Journal of neurology·2025

Same author

Transcranial Direct Current Stimulation in the Treatment of Visual Hallucinations in Charles Bonnet Syndrome: A Randomized Placebo-Controlled Crossover Trial.

Ophthalmology·2022

Search research articles

Related Experiment Video

Updated: May 9, 2026

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Art and the brain: a view from dementia.

Cosima Gretton¹, Dominic H ffytche

¹Department of Old Age Psychiatry, Institute of Psychiatry, King's College London, UK.

International Journal of Geriatric Psychiatry

|August 9, 2013

Summary

Different dementias create unique artistic signatures. Alzheimer's disease impacts spatial and color elements, fronto-temporal dementia shows perseverative themes, and Lewy body dementia art is bizarre.

Keywords:

Alzheimer's disease Fronto-temporal dementia Lewy body dementia artist cultural cognition visual perception

More Related Videos

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Group Synchronization During Collaborative Drawing Using Functional Near-Infrared Spectroscopy

Group Synchronization During Collaborative Drawing Using Functional Near-Infrared Spectroscopy

Published on: August 5, 2022

Related Experiment Videos

Last Updated: May 9, 2026

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

Group Synchronization During Collaborative Drawing Using Functional Near-Infrared Spectroscopy

Group Synchronization During Collaborative Drawing Using Functional Near-Infrared Spectroscopy

Published on: August 5, 2022

Area of Science:

Neuroscience
Art Therapy
Cognitive Neurology

Background:

Artistic creation involves complex perceptual and cognitive functions supported by widespread brain networks.
Dementia disorders differentially affect these neural systems, potentially leading to distinct artistic changes.

Purpose of the Study:

To investigate the unique artistic signatures associated with different types of dementia.
To enhance understanding of the neurobiological underpinnings of art production and higher artistic functions.

Main Methods:

A qualitative review of visual art from 14 artists diagnosed with dementia.
Analysis focused on artists with Alzheimer's disease (AD), fronto-temporal dementia (FTD), and dementia with Lewy bodies (DLB).

Main Results:

Alzheimer's disease artists exhibited significant alterations in spatial attributes, color, and contrast.
Fronto-temporal dementia artists maintained these qualities but displayed perseverative themes and a move toward realism.
Dementia with Lewy bodies artists' work was characterized by simple, unusual content.

Conclusions:

Visual art analysis offers insights into dementia's impact but requires a broader perspective including cognition, emotion, and personality.
A new classification system is proposed for future research on neural mechanisms of artistic function.